Design, synthesis, anticancer evaluation, and in silico ADMET analysis of novel thalidomide analogs as promising immunomodulatory agents

Eitemau Tebyg

• Design, synthesis, and biological evaluation of novel bioactive thalidomide analogs as anticancer immunomodulatory agents
  gan: Kotb, Anas Ramadan, et al.
  Cyhoeddwyd: (2022)
• Design, Synthesis, and Biological Evaluation of New Potential Unusual Modified Anticancer Immunomodulators for Possible Non-Teratogenic Quinazoline-Based Thalidomide Analogs
  gan: Mabrouk, Reda R., et al.
  Cyhoeddwyd: (2023)
• Design, synthesis, docking, ADMET studies, and anticancer evaluation of new 3-methylquinoxaline derivatives as VEGFR-2 inhibitors and apoptosis inducers
  gan: Alanazi, Mohammed M., et al.
  Cyhoeddwyd: (2021)
• New quinoline and isatin derivatives as apoptotic VEGFR-2 inhibitors: design, synthesis, anti-proliferative activity, docking, ADMET, toxicity, and MD simulation studies
  gan: Elkaeed, Eslam B., et al.
  Cyhoeddwyd: (2022)
• Modified Benzoxazole-Based VEGFR-2 Inhibitors and Apoptosis Inducers: Design, Synthesis, and Anti-Proliferative Evaluation
  gan: Elwan, Alaa, et al.
  Cyhoeddwyd: (2022)